Description of an ELANE Mutation in a Girl with Severe Congenital Neutropenia: A Paradigm of Targeted Genetic Screening Based on Clinical Findings

Abstract

We describe the case of a 5-year-old girl with severe congenital neutropenia presenting with recurrent skin and respiratory infections. Sequence analysis of ELANE and HAX1 genes identified a mutation in heterozygous state in exon 2 of the ELANE gene: c.157C > G (p.His53Asp), not previously described in the literature at the exon coding level. Given the autosomal dominant inheritance and the location of the mutation within a “hotspot,” this mutation was considered as clinically relevant. ELANE should be screened in patients with congenital neutropenia of no obvious etiology. A detailed medical history and clinical evaluation can prevent unnecessary investigations allowing for a targeted diagnostic strategy.

Keywords

ELANE - congenital neutropenia - pediatric hematology

• References

• 1 Boztug K, Klein C. Genetic etiologies of severe congenital neutropenia. Curr Opin Pediatr 2011; 23 (01) 21-26
• 2 Fioredda F, Calvillo M, Lanciotti M. , et al. Lethal sepsis and malignant transformation in severe congenital neutropenia: report from the Italian Neutropenia Registry. Pediatr Blood Cancer 2015; 62 (06) 1110-1112
• 3 Alizadeh Z, Fazlollahi MR, Houshmand M. , et al. Different pattern of gene mutations in Iranian patients with severe congenital neutropenia (including 2 new mutations). Iran J Allergy Asthma Immunol 2013; 12 (01) 86-92
• 4 Alizadeh Z, Fazlollahi MR, Eshghi P, Hamidieh AA, Ghadami M, Pourpak Z. Two cases of syndromic neutropenia with a report of novel mutation in G6PC3. Iran J Allergy Asthma Immunol 2011; 10 (03) 227-230
• 5 Bellanné-Chantelot C, Clauin S, Leblanc T. , et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood 2004; 103 (11) 4119-4125
• 6 Cho HK, Jeon IS. Different clinical phenotypes in familial severe congenital neutropenia cases with same mutation of the ELANE gene. J Korean Med Sci 2014; 29 (03) 452-455
• 7 Germeshausen M, Deerberg S, Peter Y, Reimer C, Kratz CP, Ballmaier M. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia. Hum Mutat 2013; 34 (06) 905-914
• 8 Newburger PE, Pindyck TN, Zhu Z. , et al. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer 2010; 55 (02) 314-317
• 9 Touw IP. Game of clones: the genomic evolution of severe congenital neutropenia. Hematology (Am Soc Hematol Educ Program) 2015; 2015: 1-7
• 10 Grantham R. Amino acid difference formula to help explain protein evolution. Science 1974; 185 (4154): 862-864
• 11 Dale DC, Link DC. The many causes of severe congenital neutropenia. N Engl J Med 2009; 360 (01) 3-5
• 12 Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis 2011; 6: 26
• 13 Donadieu J, Leblanc T, Bader Meunier B. , et al; French Severe Chronic Neutropenia Study Group; Experience of the French Severe Chronic Neutropenia Study Group. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Haematologica 2005; 90 (01) 45-53